Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 9Recruiting 5Terminated 3Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 136Thoracic 29Gynecologic 24Head & Neck 19Genitourinary 19Gastrointestinal 19Dermatologic 13Sarcoma 5Other solid neoplasm 5Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Endocrine 1CNS 1

Conditions

Lymphoma 159Lymphoma, Non-Hodgkin 143Leukemia, Lymphocytic, Chronic, B-Cell 137Precursor Cell Lymphoblastic Leukemia-Lymphoma 132Lymphoma, Follicular 114Lymphoma, Large B-Cell, Diffuse 111Lymphoma, Mantle-Cell 74Lymphoma, B-Cell 73Hodgkin Disease 66Multiple Myeloma 61Leukemia 58Burkitt Lymphoma 49Lymphoma, B-Cell, Marginal Zone 48Leukemia, Myeloid, Acute 48Recurrence 46Neoplasms 45Myelodysplastic Syndromes 43Hematologic Neoplasms 35Waldenstrom Macroglobulinemia 27Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Lymphoma, T-Cell 16Leukemia, Biphenotypic, Acute 16Leukemia, B-Cell 16Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 15Mycosis Fungoides 15Lymphoproliferative Disorders 15Myeloproliferative Disorders 14Lymphoma, T-Cell, Peripheral 14Lymphoma, T-Cell, Cutaneous 14Breast Neoplasms 14

Interventions

HMPL-013 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Triple Negative Breast Neoplasms × Lymphoid × Clear all
NCT05565417 2025-10-16

Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas

Immunitas Therapeutics

Phase 1/2 Active not recruiting
67 enrolled
BreastGastrointestinalHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Colorectal Neoplasms, Lymphoma, Large B-Cell, Diffuse, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡